58 Biggest Movers From Yesterday

Gainers

• BSQUARE Corporation BSQR shares jumped 206.9% to close at $8.04 on Tuesday on abnormally-high volume possibly amid increased attention from retail investors. Bsquare is a software development firm that is both Microsoft-embedded and an IoT partner.
• Cerevel Therapeutics Holdings, Inc. CERE shares surged 136.2% to close at $29.69 on Tuesday after the company announced positive results from its Phase 1b clinical trial of CVL-231 in adult patients with schizophrenia. CVL-231 was generally well-tolerated, and discontinuation rates were similar between CVL-231 and placebo in the six weeks of dosing, at 22% each.
• Marin Software Incorporated MRIN climbed 130.7% to settle at $17.30 after jumping around 97% on Monday. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.
• Exela Technologies, Inc. XELA climbed 59.2% to close at $2.34 after gaining over 5% on Monday.
• Bridgeline Digital, Inc. BLIN jumped 36.7% to settle at $3.39.
• Infobird Co., Ltd IFBD jumped 30.7% to settle at $5.07.
• Universe Pharmaceuticals INC UPC shares climbed 25% to close at $3.70 after declining 4% on Monday. Universe Pharmaceuticals, last month, entered into Letter of Intent for strategic cooperation with Kitanihon Pharmaceutical.
• Graphite Bio, Inc. GRPH climbed 21.6% to settle at $27.60. The company recently priced its IPO at $17a share.
• The OLB Group, Inc. OLB surged 21.1% to close at $6.49.
• Amesite Inc. AMST gained 21% to close at $3.11.
• Troika Media Group, Inc. TRKA surged 20.6% to close at $3.45.
• Verve Therapeutics, Inc. VERV jumped 20.6% to settle at $54.25.
• Sphere 3D Corp. ANY jumped 19.8% to close at $3.09.
• Evolving Systems, Inc. EVOL surged 19.4% to settle at $2.77.
• Quhuo Limited QH surged 19.2% to settle at $4.10.
• Auddia Inc. AUUD shares gained 19% to close at $7.01 after the company announced the release and national launch of its flagship Auddia app ahead of schedule.
• Greenlane Holdings, Inc. GNLN gained 17% to close at $4.82.
• Nephros, Inc. NEPH rose 16.8% to close at $10.68.
• XOMA Corporation XOMA surged 16.6% to settle at $37.68. Aegis Capital initiated coverage on XOMA with a Buy rating and announced a price target of $60.
• Holicity Inc. HOL gained 15.9% to settle at $13.33.
• Alzamend Neuro, Inc. ALZN surged 15.2% to close at $11.06.
• Baosheng Media Group Holdings Limited BAOS rose 14.8% to settle at $3.89.
• Bon Natural Life Limited BON surged 14.7% to close at $7.90. The company recently priced its IPO at $5 per share.
• Intellia Therapeutics, Inc. NTLA rose 13.6% to close at $151.61. Intellia Therapeutics commenced an underwritten public offering of $400 million shares of its common stock.
• Red Cat Holdings, Inc. RCAT gained 13.5% to settle at $2.85.
• Century Therapeutics, Inc. IPSC rose 13.4% to close at $27.63. The company recently priced its IPO at $20 a share.
• Translate Bio, Inc. TBIO gained 12.5% to close at $25.66. Sanofi and Translate Bio recently said they have initiated a Phase 1 clinical trial evaluating an mRNA-based investigational vaccine against seasonal influenza.
• Global Internet of People, Inc. SDH surged 11.1% to settle at $3.20.
• Smart Sand, Inc. SND rose 8.2% to close at $3.30. Smart Sand entered into a $35M settlement with US Well Services, LLC. Evercore ISI Group upgraded Smart Sand from Underperform to In-Line and announced a $4 price target.
• Diginex Limited EQOS climbed 8.2% to close at $6.89.
• LMP Automotive Holdings, Inc. LMPX gained 7.1% to close at $17.67 ahead of quarterly earnings.
• Jefferies Financial Group Inc. JEF shares surged 7.1% to settle at $34.22 after the company reported strong Q2 results and raised its quarterly dividend.
• Digital Brands Group, Inc. DBGI gained 5.3% to close at $5.78. Digital Brands, on Monday, reported first-quarter FY21 revenue of $408 thousand, down 84% year-on-year.
• Morgan Stanley MS shares rose 3.4% to close at $90.64 after the company announced it raised its quarterly dividend from $0.35 to $0.70 per share and announced a $12 billion buyback.

Check out these big penny stock gainers and losers

Losers

• Better Choice Company Inc BTTR shares dipped 44.3% to close at $4.11 on Tuesday after the company reported the pricing of its underwritten public offering of 8,000,000 shares at $5.00 per share.
• DiaMedica Therapeutics Inc. DMAC fell 33.9% to close at $4.74 after the company announced positive interim results from its Phase 2 REDUX trial of DM199 in chronic kidney disease. DM199, the company noted, is demonstrating clinically meaningful improvements in kidney function in Cohorts 1 and 2, as measured by a simultaneously stabilizing estimated glomerular filtration rate and decreasing urine albumin-to-creatinine ratio.
• MediWound Ltd. MDWD declined 27.8% to close at $4.07. Vericel’s development partner, MediWound, received a complete response letter from FDA regarding the NexoBrid application seeking approval for eschar removal in adults with deep partial-thickness or full-thickness burns.
• ReShape Lifesciences Inc. RSLS fell 27.8% to close at $5.52 after the company enters into a warrant exercise transaction for $46.2 million in gross proceeds.
• Celcuity Inc. CELC shares declined 21.3% to close at $24.33 after the company priced its underwritten public offering of 2,250,000 shares at $25.00 per share.
• Anavex Life Sciences Corp. AVXL declined 18.1% to close at $23.63. Anavex Life Sciences recently announced ANAVEX2-73 improved both primary cognitive and secondary MDS-UPDRS efficacy endpoints with significant biomarker correlation in placebo-controlled Phase 2 clinical trial for treatment of Parkinson's.
• AMREP Corporation AXR fell 17.1% to close at $10.36.
• Kiromic BioPharma, Inc. KRBP declined 16.9% to close at $6.64 after dropping 20% on Monday.
• Montauk Renewables, Inc. MNTK fell 16.6% to settle at $7.09.
• Sensei Biotherapeutics, Inc. SNSE declined 16% to close at $9.10 after the company said it is reprioritizing its pipeline programs to focus on its product candidates, including its multi-antigenic next generation ImmunoPhage candidate, now referred to as SNS-401-NG, and its monoclonal antibody SNS-VISTA candidate. Oppenheimer downgraded Sensei Biotherapeutics from Outperform to Perform.
• Nam Tai Property Inc. NTP dropped 15.1% to settle at $22.27. Nam Tai Property’s shareholder, IsZo Capital, late Sunday issued an update on Nam Tai's appeal of voided private placement.
• Vericel Corporation VCEL shares declined 14.8% to close at $57.77 after MediWound announced it received a Complete Response Letter from the FDA for its NexoBrid Biologics License Application.
• Alfi, Inc. ALF fell 14.5% to close at $15.90.
• Virgin Galactic Holdings, Inc. SPCE fell 14.3% to close at $47.02 as the stock pulled back after spiking last week following FAA approval for its passenger flight license.
• Brooklyn ImmunoTherapeutics, Inc. BTX dropped 13.7% to close at $18.43. Brooklyn ImmunoTherapeutics recently executed a non-binding letter of intent to acquire Novellus Therapeutics, a company developing engineered mesenchymal stem cell (MSC) therapies using mRNA cell reprogramming and gene editing technologies licensed from Factor Bioscience.
• Avidity Biosciences, Inc. RNA dipped 12.7% to settle at $22.88.
• Alpha Teknova, Inc. TKNO shares declined 12.4% to close at $24.51. The company recently priced its IPO at $16 per share.
• The Beachbody Company, Inc. BODY shares dropped 12.2% to settle at $11.19.
• Metamaterial Exchangeco Inc. MMAT fell 11.7% to close at $7.03. Meta Materials recently announced closing of the business combination with Torchlight Energy Resources.
• Aligos Therapeutics, Inc. ALGS fell 11% to close at $21.15 after the company announced a proposed public offering of 4 million shares of common stock.
• X Financial XYF declined 10.1% to close at $14.80 after gaining over 9% on Monday.
• Herman Miller, Inc. MLHR dropped 6.9% to close at $44.63. Herman Miller reported better-than-expected results for its fourth quarter. However, the company issued weak earnings forecast for the current quarter.
• LexinFintech Holdings Ltd. LX fell 5.9% to close at $12.46. The company last week announced a partnership with Huawei.
• Zosano Pharma Corporation ZSAN shares fell 4.4% to close at $0.9657. Zosano Pharma’s filing showed registration for $30 million common stock offering.